Emory University and Micron Biomedical announced the first clinical trial of a novel rotavirus vaccine, CC24, delivered via dissolvable microarray ...

Microarray technology has led the way towards global and parallel analysis of cellular processes. The use of microarrays in transcription profiling and genotyping is now well established and the ...

The expectation that microarray technology will play a large role in shaping the future of pharmaceutical development and diagnostics has increased due to new products and applications. Microarrays ...

For small molecules, Arrayjet took processes pioneered by groups at Massachusetts Institute of Technology, the National Cancer Institute and Scripps, and made them accessible with simplified ...

Microarray technology has come of age as a powerful approach to revealing the genome and its dynamic expression through the application of gene-hybridization or gene-expression microarrays.

PEPperPRINT launches its next-generation peptide microarray platform, cLIFT; paves the way for innovative biomedical research applications: Heidelberg Thursday, June 12, 2025, 10: ...

Courtesy of CombiMatrix The research community's rapid acceptance of microarrays notwithstanding, technical challenges remain. Biochip developers continue to grapple with these issues while upgrading ...

Microarray technology has revolutionized the field of genetics, providing scientists with powerful tools to explore the intricate complexities of human genetics. This innovative technique allows ...

Microarrays in a Microtube. Image courtesy of CLONDIAG Companies in the microarray sector are trying to take the technology out of core facilities and put it into the hands of individual researchers ...

At PathogenDX, we’re bringing microbial testing into the modern age. Our patent-winning scientists have invented a game-changing DNA-based microarray technology that accelerates the testing and ...

In response, researchers have developed HiTIP-seq, a microarray-based high-throughput in situ tagged immunoprecipitation sequencing technology.

Mr. Schena described himself to investors as “the father of microarray technology” and falsely stated that he was on the shortlist for the Nobel Prize, the Justice Department said.